Published: 2010-06-03 15:31:40 CEST
NASDAQ OMX Nordic - Investor News
Semi-annual review of OMX Copenhagen 20 Index
Stockholm, June 3, 2010 - The NASDAQ OMX Group, Inc. (NASDAQ:NDAQ) announced
today the result of the semi-annual review of the OMX Copenhagen 20 Index
(NASDAQ OMX Copenhagen: OMXC20), which will become effective with the market
open on Monday, June 21, 2010. 

As a result of the re-ranking NASDAQ OMX will add Coloplast to the OMXC20 Index
and remove Genmab. 

The OMXC20 Index is the NASDAQ OMX Copenhagen's tradable index. It was
introduced July 3, 1989 as an underlying instrument for futures and options.
The OMXC20 Index has a base value of 100 and is weighted in terms of free
floated market value. 

The OMX Copenhagen 20 Index constituents effective June 21, 2010 are:

A.P. Møller - Mærsk A	 	
A.P. Møller - Mærsk B	 	
Carlsberg A/S B		 	
Coloplast B		 	
D/S Norden			 	
Danisco		 	
Danske Bank			 	
DSV		 	
FLSmidth & Co.			 	
Jyske Bank A/S		 	
Lundbeck
NKT Holding
Nordea Bank AB
Novo Nordisk B
Novozymes B
Sydbank
Topdanmark
TrygVesta
Vestas Wind Systems
William Demant Holding


About NASDAQ OMX Index Products
NASDAQ OMX is a global leader in creating and licensing strategy indexes and is
home to the most widely watched indexes in the world. As a premier,
full-service provider, NASDAQ OMX is dedicated to designing powerful indexes
that are in sync with a continually changing market environment. Utilizing the
expanded coverage of our global company, NASDAQ OMX has nearly 1,500 diverse
equity, commodity and fixed-income indexes in the U.S., Europe, and throughout
world. In addition, our calculation, licensing and marketing support provide
the tools to measure and replicate global markets. The NASDAQ OMX Index Group
range of services covers the entire business process from index design to
calculation and dissemination. For more information about NASDAQ OMX indexes,
visit https://indexes.nasdaqomx.com/. 


About NASDAQ OMX
The NASDAQ OMX Group, Inc. is the world's largest exchange company. It delivers
trading, exchange technology and public company services across six continents,
with more than 3,600 listed companies. NASDAQ OMX offers multiple capital
raising solutions to companies around the globe, including its U.S. listings
market, NASDAQ OMX Nordic, NASDAQ OMX Baltic, NASDAQ OMX First North, and the
U.S. 144A sector. The company offers trading across multiple asset classes
including equities, derivatives, debt, commodities, structured products and
exchange-traded funds. NASDAQ OMX technology supports the operations of over 70
exchanges, clearing organizations and central securities depositories in more
than 50 countries.  NASDAQ OMX Nordic and NASDAQ OMX Baltic are not legal
entities but describe the common offering from NASDAQ OMX exchanges in
Helsinki, Copenhagen, Stockholm, Iceland, Tallinn, Riga, and Vilnius. For more
information about NASDAQ OMX, visit www.nasdaqomxnordic.com. Please follow
NASDAQ OMX on Facebook (www.facebook.com/nasdaqomxnorden) and Twitter
(www.twitter.com/nasdaqomxnordic). 


Cautionary Note Regarding Forward-Looking Statements 
The matters described herein contain forward-looking statements that are made
under the Safe Harbor provisions of the Private Securities Litigation Reform
Act of 1995. These statements include, but are not limited to, statements about
NASDAQ OMX's products and offerings. We caution that these statements are not
guarantees of future performance. Actual results may differ materially from
those expressed or implied in the forward-looking statements. Forward-looking
statements involve a number of risks, uncertainties or other factors beyond
NASDAQ OMX's control. These factors include, but are not limited to factors
detailed in NASDAQ OMX's annual report on Form 10-K, and periodic reports filed
with the U.S. Securities and Exchange Commission. We undertake no obligation to
release any revisions to any forward-looking statements. There can be no
assurance that the FSA will give the NASDAQ OMX applicant the authorization and
permissions which it seeks. 

- # -

Media Contacts:  
Carl Norell
+46 8 405 66 39
carl.norell@nasdaqomx.com


omxc20_0603_2010.pdf